Preclinical Drug Development Solutions

Preclinical CRO Services for Global Drug Development

At HT Biosciences, we empower pharmaceutical and biotech innovators with comprehensive preclinical CRO services designed to streamline drug development from concept to IND submission. Our state-of-the-art facilities, globally compliant protocols, and deep scientific expertise ensure reliable data, faster timelines, and reduced risks for your preclinical programs.

Drug Efficacy Testing in Preclinical Studies

Huateng Bio provides comprehensive preclinical efficacy studies to evaluate therapeutic potential, optimize drug candidates, and generate robust data packages for IND submissions. Our customized models bridge the gap between in vitro findings and clinical outcomes.

Learn More

ADME/PK Profiling Services

At HuaTeng Bio, we deliver end-to-end ADME/PK profiling services to optimize drug discovery and development, ensuring robust pharmacokinetic and safety data for small molecules, biologics, and novel modalities. Our globally compliant studies bridge preclinical and clinical phases, empowering you to prioritize candidates, mitigate attrition risks, and meet regulatory milestones.

Learn More

Non-GLP Toxicology & Safety Pharmacology

Huateng Bio provides end-to-end GLP-certified safety & toxicology studies for global clients. Expertise in small (rodent) and large animal models (NHP/canine). OECD, FDA, ICH compliant. Fast-track your drug development.

Learn More

Why Choose Huateng Bio for GLP-Compliant Testing?

Global Compliance: AAALAC-accredited facilities with IACUC protocols aligned with EU Directive 2010/63/EU and USDA standards.

Advanced Imaging: DSA, IVUS, angiography, and micro-CT for real-time device performance tracking.

Custom Model Development: Species-specific animal models for complex disease states.

Histopathology Suite: SEM/TEM analysis with GLP-grade reporting for PMDA/CE Mark submissions.

Preclinical Drug Development Solutions